Efficacy of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia - Retrospective Case Series

Circulation Journal

Volumn 74, Issue 5, 2010, Pages 864-869

  Komura, Satoru ^a   Chinushi, Masaomi ^a   Furushima, Hiroshi ^a   Hosaka, Yukio ^a   Izumi, Daisuke ^a   Iijima, Kenichi ^a   Watanabe, Hiroshi ^a   Yagihara, Nobue ^a   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Antiarrhythmic agents; Arrhythmia; Ventricular tachycardia

Indexed keywords

LIDOCAINE; PROCAINAMIDE;

ADULT; ARTICLE; CONSCIOUSNESS; CONSCIOUSNESS DISORDER; CONTROLLED STUDY; DRUG EFFICACY; ELECTROCARDIOGRAM; ELECTROPHYSIOLOGY; FEMALE; HEART INFARCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SUSTAINED MONOMORPHIC VENTRICULAR TACHYCARDIA; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA;

ADULT; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; BLOOD PRESSURE; ELECTROCARDIOGRAPHY; FEMALE; GUIDELINES AS TOPIC; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; PROCAINAMIDE; RETROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR;

EID: 77951704556     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0932     Document Type: Article

References (40)

1. Myerburg RJ, Castellanos A. Cardiac arrest and sudden death. In: Braunwald E, editor. Heart disease: A textbook of cardiovascular medicine, 5th edn. Vol 2. Philadelphia: WB Saunders, 2008; 933-974.
2. Ruskin JN, DiMarco JP, Garan H. Out-of-hospital cardiac arrest: Electrophysiologic observations and selection of long-term anti arrhythmic therapy. N Engl J Med 1980; 303: 607.
3. Bayes de Luna A, Coumel P, Leclercq JF. Ambulatory sudden car diac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989; 117: 151-159.
4. Kimura S, Aizawa Y and the Study Groups for Sudden Cardiac Death during Holter Recording. The first report of sudden car diac death during Holter ECG. J Electrocardiol 2008; 28: 1-8 (in Japanese).
5. Field JM, editor. ACLS resources text for instructors and experi enced providers. AHA Learn and Live. Dallas, Texas: American Heart Association, 2008.
6. ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary. Circulation 2006; 114: 1088-1132.
7. Wellens HJJ, Bar FW, Lie KI, Duren DR, Dohmen HJ. Effect of procainamide, propranolol and verapamil on mechanism of tachy cardia in patients with chronic recurrent ventricular tachycardia. Am J Cardiol 1977; 40: 579-585.
8. Callans DJ, Marchlinski FE. Dissociation of termination and prevention of inducibility of sustained ventricular tachycardia with infusion of procainamide: Evidence for distinct mechanisms. J Am Coll Cardiol 1992; 19: 111-117.
9. Gorgels AP, van de Dool A, Hofs A, Mulleneers R, Smeets JL, Vos MA, et al. Comparison of procainamide and lidocaine interminating sustained monomorphic ventricular tachycardia. Am J Cardiol 1996; 78: 43-46.
10. Armengol RE, Graff J, Baerman JM, Swiryn S. Lack of effective ness of lidocaine for sustained, wide QRS complex tachycardia. Ann Emerg Med 1989; 18: 254-257.
11. Griffith MJ, Linker NJ, Garratt CJ, Ward DE, Camm AJ. Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia. Lancet 1990; 336: 670-673.
12. Ho DSW, Zecchin RP, Richards DAB, Uther JB, Ross DL. Double- blinded trial of lignocaine versus sotalol for acute termination of spontaneous sustained ventricular tachycardia. Lancet 1994; 344: 18-23.
13. Marril KA, Greenberg GT, Kay D, Nelson BK. Analysis of the treatment of spontaneous sustained ventricular tachycardia. Acad Emerg Med 1997; 4: 1122-1128.
14. Somberg JC, Bailin SJ, Haffajeee CI, Paladino WP, Kerin NZ, Bridges D, et al; Amio-Aqueous Investigators. Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia. Am J Cardiol 2002; 90: 853-859.
15. Nasir N Jr, Taylor A, Doyle TK, Pacifico A. Evaluation of intra venous lidocaine for the termination of sustained monomorphic ventricular tachycardia in patients with coronary artery disease with or without healed myocardial infarction. Am J Cardiol 1994; 74: 1183-1186.
16. Kodama I, Aizawa Y, Inoue H, Ogawa S, Okumura K, Atarashi H, et al Guideline for Drug Treatment of Arrhythmias (JCS 2009). http://www.jcirc.or.jp/guideline/pdf/JCS2009_kodama_h.pdf (accessed March 18, 2010).
17. Tomlinson DR, Cherian P, Betts TR, Bashir Y. Intravenous amiod arone for the pharmacological termination of hemodynamically-tolerated sustained ventricular tachycardia: Is bolus dose amiodarone an appropriate first-line treatment? Emerg J Med 2008; 25: 15-18.
18. Marill KA, deSouza IS, Nishijima DK, Stair TO, Setnik GS, Ruskin JN. Amiodarone is poorly effective for the acute termination of ventricular tachycardia. Ann Emerg Med 2006; 47: 217-224.
19. Naitoh N, Tagawa M, Yamaura M, Taneda K, Furushima H, Aizawa Y. Comparison of electrophysiologic effects of intravenous E-4031 and MS-551, novel class III antiarrhythmic agents, in patients with ventricular tachyarrhythmias. Jpn Heart J 1998; 39: 457-467.
20. Washizuka T, Chinushi M, Watanabe H, Hosaka Y, Komura S, Sugiura H, et al. Nifekalant hydrochloride suppresses severe electrical storm in patients with malignant ventricular tachyarrhythmias. Circ J 2005; 69: 1508-1513.
21. Yusu S, Ikeda T, Mera H, Miyakoshi M, Miwa Y, Abe A, et al. Effects of intravenous nifekalant as a lifesaving drug for severe ventricular tachyarrhythmias complicating acute coronary syndrome. Circ J 2009; 73: 2021-2028.
22. Josephson ME. Recurrent ventricular tachycardia. In: Clinical elec trophysiology: Techniques and interpretation. 2nd edn. Philadelphia: Lea & Febriger, 1993; 417-615.
23. Aizawa Y, Niwano S, Chinushi M, Tamura M, Kusano Y, Miyajima T, et al. Incidence and mechanism of interruption of ventricular tachycardia with rapid ventricular pacings. Circulation 1992; 82: 589-595.
24. Aizawa Y, Satoh M, Suzuki K, Aizawa M, Funazaki T, Miyajima S, et al. Early experiences of endocardial catheter mapping of the left ventricle in patients with sustained ventricular tachycardia: Efficacy, safety and complications. Jpn Circ J 1987; 51: 1283-1288.
25. Stanton MS. Class I antiarrhythmic drugs: Quinidine, procainamide, disopyramide, lidocaine, mexiletine, tocainide, phenytoin, moricizine, flecainide, and propafenon. In: Zipes P, Jallife J, editors. Cardiac electrophysiology: From cell to bedside. 3rd edn. Philadelphia: Saunders, 2006; 890-903.
26. American Heart Association. Textbook of advanced cardiac life support. Dallas, Texas: AHA, 1989.
27. Stevenson WG, Khan H, Sager P, Saxon LA, Middlekauff HR, Natterson PD, et al. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachy cardia late after myocardial infarction. Circulation 1993; 88: 1647-1670.
28. Aizawa Y, Naitoh N, Kitazawa H, Kusano Y, Uchiyama H, Washizuka T, et al. Frequency of presumed reentry with an excitable gap in sustained ventricular tachycardia unassociated with coronary artery disease. Am J Cardiol 1993; 72: 916-921.
29. Janse MJ, Witt AL. Electrophysiological mechanism of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev 1989; 69: 1049-1169.
30. Josephson ME, Horowitz LN, Farshidi A, Spear J, Kastor J, Moore E. Recurrent sustained ventricular tachycardia II: Endocardial map ping. Circulation 1978; 57: 440-447.
31. Niwano S, Fukaya H, Yuge M, Imaki R, Hirasawa S, Sasaki T, et al. Role of electrophysiologic study (EPS)-guided preventive ther apy for the management of ventricular tachyarrhythmias in patients with heart failure. Circ J 2008; 72: 268-273.
32. Kay GN, Epstein AE, Plumb VL. Preferential effect of procain amide on the reentrant circuit of ventricular tachycardia. J Am Coll Cardiol 1989; 14: 382-390.
33. Schmitt C, Kadish AH, Balke WC, Turk K, Buxton AE, Josephson ME, et al. Cycle length-dependent effects on normal and abnormal intraventricular electrograms; effect of procainamide. J Am Coll Cardiol 1988; 12: 395-403.
34. Schmitt CG, Kadish AH, Marchlinski FE, Miller JM, Buxton AE, Josephson ME. Effects of lidocaine and procainamide on normal and abnormal intraventricular electrograms during sinus rhythm. Circulation 1988; 77: 1030-1037.
35. Stamato NJ, Frame LH, Rosenthal ME, Almendral JM, Gottlieb CD, Josephson ME. Procainamide-induced slowing of ventricular tachycardia with insights from analysis of resetting response pat tern. Am J Cardiol 1989; 63: 1455-1461.
36. Aizawa Y, Tanabe Y, Naitoh N, Washizuka T, Shibata A, Josephson ME. Procainamide induced change of the width of the zone of entrainment and its relation to the inducibility of reentrant ventricu lar tachycardia. Pacing Clin Electrophysiol 1997; 20: 2789-2798.
37. Sharma AD, Purves P, Yee R, Klein G, Jablonsky G, Kostuk WJ. Hemodynamic effects of intravenous procainamide during ventricu lar tachycardia. Am Heart J 1990; 119: 1034-1041.
38. Kim SY, Benowitz NL. Poisoning due to class IA antiarrhythmic drugs: Quinidine, procainamide and disopyramide. Drug Saf 1990; 5: 393-420.
39. Lie KI, Wellens HJ, van Capelle FJ, Durrer D. Lidocaine in the prevention of primary ventricular fibrillation: A double-blind, ran domized study of 212 consecutive patients. N Engl J Med 1974; 291: 1324-1326.
40. Vassallo P, Trohman RG. Prescribing amiodarone: An evidence- based review of clinical indication. JAMA 2007; 298: 1312-1322.